Enfusion Stock Odds of Future Stock Price Finishing Over 12.23

ENFN Stock  USD 10.10  0.21  2.12%   
Enfusion's future price is the expected price of Enfusion instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Enfusion performance during a given time horizon utilizing its historical volatility. Check out Enfusion Backtesting, Enfusion Valuation, Enfusion Correlation, Enfusion Hype Analysis, Enfusion Volatility, Enfusion History as well as Enfusion Performance.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
  
At this time, Enfusion's Price Fair Value is very stable compared to the past year. Please specify Enfusion's target price for which you would like Enfusion odds to be computed.

Enfusion Target Price Odds to finish over 12.23

The tendency of Enfusion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 12.23  or more in 90 days
 10.10 90 days 12.23 
near 1
Based on a normal probability distribution, the odds of Enfusion to move over $ 12.23  or more in 90 days from now is near 1 (This Enfusion probability density function shows the probability of Enfusion Stock to fall within a particular range of prices over 90 days) . Probability of Enfusion price to stay between its current price of $ 10.10  and $ 12.23  at the end of the 90-day period is about 1.21 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.26 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Enfusion will likely underperform. Additionally Enfusion has an alpha of 0.2083, implying that it can generate a 0.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Enfusion Price Density   
       Price  

Predictive Modules for Enfusion

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enfusion. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
8.1910.2112.23
Details
Intrinsic
Valuation
LowRealHigh
8.7310.7512.77
Details
Naive
Forecast
LowNextHigh
7.799.8111.82
Details
9 Analysts
Consensus
LowTargetHigh
9.2510.1711.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Enfusion. Your research has to be compared to or analyzed against Enfusion's peers to derive any actionable benefits. When done correctly, Enfusion's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Enfusion.

Enfusion Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Enfusion is not an exception. The market had few large corrections towards the Enfusion's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Enfusion, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Enfusion within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.21
β
Beta against Dow Jones1.26
σ
Overall volatility
0.55
Ir
Information ratio 0.12

Enfusion Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enfusion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enfusion can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Enfusion is unlikely to experience financial distress in the next 2 years
Enfusion has a very strong financial position based on the latest SEC filings
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Enfusion Third Quarter 2024 Earnings Misses Expectations

Enfusion Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Enfusion Stock often depends not only on the future outlook of the current and potential Enfusion's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enfusion's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding129.4 M
Cash And Short Term Investments35.6 M

Enfusion Technical Analysis

Enfusion's future price can be derived by breaking down and analyzing its technical indicators over time. Enfusion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Enfusion. In general, you should focus on analyzing Enfusion Stock price patterns and their correlations with different microeconomic environments and drivers.

Enfusion Predictive Forecast Models

Enfusion's time-series forecasting models is one of many Enfusion's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Enfusion's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Enfusion

Checking the ongoing alerts about Enfusion for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Enfusion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Enfusion is unlikely to experience financial distress in the next 2 years
Enfusion has a very strong financial position based on the latest SEC filings
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Enfusion Third Quarter 2024 Earnings Misses Expectations
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:
Check out Enfusion Backtesting, Enfusion Valuation, Enfusion Correlation, Enfusion Hype Analysis, Enfusion Volatility, Enfusion History as well as Enfusion Performance.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Earnings Share
0.04
Revenue Per Share
2.155
Quarterly Revenue Growth
0.154
Return On Assets
0.0592
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.